Ypsomed Holding AG header image

Ypsomed Holding AG

YPSN

Equity

ISIN CH0019396990 / Valor 1939699

SIX Swiss Exchange (2026-04-22)
CHF 285.80-1.02%

Ypsomed Holding AG
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Ypsomed Holding AG is a Swiss company specializing in the development and production of injection and infusion systems for self-medication, primarily serving the pharmaceutical and biotechnology sectors. The company operates through two main divisions: Ypsomed Delivery Systems (YDS) and mylife Diabetescare. YDS provides a wide array of technologies and services designed to ensure reliable and user-friendly injection systems, catering to companies that develop and market injectable therapies. Meanwhile, the mylife Diabetescare brand offers a comprehensive range of products and services aimed at simplifying self-treatment for individuals with diabetes, enhancing their ability to manage their condition discreetly and effectively. Ypsomed's focus on innovation and user-centric design positions it as a key player in the medical technology industry, particularly in the field of self-administered drug delivery solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-8.45%1Y
43.3%3Y
87.7%5Y

Performance

32.9%1Y
31.8%3Y
31.2%5Y

Volatility

Market cap

5059 M

Market cap (USD)

Daily traded volume (Shares)

18,372

Daily traded volume (Shares)

1 day high/low

340 / 328

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.50
Khiem Tran
Switzerland, 02 Nov 2025
star star star star star
There is potential but it’s right now lagging.
Khiem Tran
Switzerland, 31 Oct 2025
star star star star star
Ypsomed is under Track because of the high potential innovation and R&D.

EQUITIES OF THE SAME SECTOR

Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.16%USD 19.35
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%USD 15.46
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%EUR 13.73
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.26%EUR 73.45
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.41%EUR 8.37
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.00%USD 32.84
Medtronic PLC
Medtronic PLC Medtronic PLC Valor: 25187155
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.53%USD 82.00
Krystal Biotech Inc
Krystal Biotech Inc Krystal Biotech Inc Valor: 38026052
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%USD 272.66
ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.22%USD 8.10
LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.70%USD 111.90